316 related articles for article (PubMed ID: 5519048)
1. [Oral antidiabetic monotherapy and combination treatment with glybenclamide (HB 419) and biguanides of insulin receiving diabetics of the adult type].
Knick B; Wendt O; Konder ML; Netter P
Med Klin; 1970 Jan; 65(3):109-12. PubMed ID: 5519048
[No Abstract] [Full Text] [Related]
2. [Personal experience on the use of glybenclamide (a new oral hypoglycemic agent)].
Rodríguez-Miñón JL; Arrieta F; Herrera JL
Rev Clin Esp; 1970 May; 117(4):371-4. PubMed ID: 5471526
[No Abstract] [Full Text] [Related]
3. [Clinical studies on the effect of a new oral antidiabetic agent Glybenclamide (HB 419)].
Schmitt H; Höhler H; Daweke H; Jahnke K
Dtsch Med Wochenschr; 1969 Apr; 94(16):824-9. PubMed ID: 5776707
[No Abstract] [Full Text] [Related]
4. [Oral treatment of diabetes mellitus with the new sulfonylurea tolazamide].
Vogel G; Krummel E
Arzneimittelforschung; 1969 Jul; 19(7):1128-30. PubMed ID: 5394514
[No Abstract] [Full Text] [Related]
5. [Insulin therapy in 1970 and various reflections on the oral treatment of diabetes].
Deuil R
Acquis Med Recent; 1970; ():65-81. PubMed ID: 5526183
[No Abstract] [Full Text] [Related]
6. [Comparative study of oral treatment in diabetes].
Romani JD
Sem Hop; 1969 May; 45(25):1768-76. PubMed ID: 4308469
[No Abstract] [Full Text] [Related]
7. [Treatment of diabetes mellitus with hypoglycemic agents by oral route].
Confalonieri C
Resen Clin Cient; 1970; 39(9):213-20. PubMed ID: 4921155
[No Abstract] [Full Text] [Related]
8. [Clinical report of the experience in therapy with oral antidiabetic agent HB 419].
Leubner H
Wien Klin Wochenschr; 1969 Sep; 81(36):625-8 passim. PubMed ID: 4897449
[No Abstract] [Full Text] [Related]
9. [Oral diabetes therapy with special reference to a new antidiabetic (Glybenclamid-HB 419)].
Lenhardt A
Wien Med Wochenschr; 1969 Oct; 119(41):685-90. PubMed ID: 5351176
[No Abstract] [Full Text] [Related]
10. [Therapy of diabetes mellitus with combination of sulfonyl urea and biguanide].
Aoki H; Kawanishi M; Nagano M
Saishin Igaku; 1969 Mar; 24(3):610-4. PubMed ID: 5772840
[No Abstract] [Full Text] [Related]
11. Clinical experience with the oral administration of the antidiabetic buformin.
Sieberová R
Rev Czech Med; 1971; 17(4):219-21. PubMed ID: 5122079
[No Abstract] [Full Text] [Related]
12. [Clinical trial of a new oral antidiabetic: glypizide].
Paes E; Gomes FJ; Pinto RE; De Alburquerque MA; Farinha H
Rev Iber Endocrinol; 1974; 21(125):459-62, 466-6, 469-70 passim. PubMed ID: 4422452
[No Abstract] [Full Text] [Related]
13. [Testing a new antidiabetic (Glibenclamid) in hospitalized and ambulatory diabetics].
Belser F; Brögli H; Constam G; Zollikofer H
Schweiz Rundsch Med Prax; 1970 Apr; 59(16):598-601. PubMed ID: 4997187
[No Abstract] [Full Text] [Related]
14. [Oral hypoglycemic agents in the treatment of diabetes mellitus].
Thervet F
Cah Med; 1970 Sep; 11():Suppl:77-83. PubMed ID: 5454628
[No Abstract] [Full Text] [Related]
15. [Combined administration of insulin and oral agents].
Tasaka H
Nihon Rinsho; 1973 Jul; 31(7):2286-93. PubMed ID: 4795329
[No Abstract] [Full Text] [Related]
16. [Combined administration of oral agents in insulin therapy].
Oneta A
Nihon Rinsho; 1973 Jul; 31(7):2293-7. PubMed ID: 4795330
[No Abstract] [Full Text] [Related]
17. Acute and chronic studies using a new oral hypoglycemic agent, glyburide.
Herrold JN; Tzagournis M; Skillman TG
Metabolism; 1971 Apr; 20(4):414-21. PubMed ID: 4927607
[No Abstract] [Full Text] [Related]
18. Clinical and metabolic observations with a new synthetic oral antidiabetic agent, glipizide.
D'Onofrio F; Pempinello R; Romis L
Arzneimittelforschung; 1972 Nov; 22(11):1879-81. PubMed ID: 4679059
[No Abstract] [Full Text] [Related]
19. [Step-wise drug therapy in type 2 diabetes mellitus].
König K; Schatz H
Z Arztl Fortbild Qualitatssich; 1998 Sep; 92(7):467-73. PubMed ID: 9842691
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological and clinical evaluation of the activity and tolerance of a new oral antidiabetic compound, glydiazinamide or K 4024.
Parodi FA
Isr J Med Sci; 1972 Jun; 8(6):888-92. PubMed ID: 5051831
[No Abstract] [Full Text] [Related]
[Next] [New Search]
